FAM237A, rather than peptide PEN and proCCK56-63, is a ligand of the orphan receptor GPR83

G protein-coupled receptor 83 (GPR83) is primarily expressed in the brain and is implicated in the regulation of energy metabolism and some behaviors. Recently, the PCSK1N/proSAAS-derived peptide PEN, the procholecystokinin-derived peptide proCCK56-63, and family with sequence similarity 237 member A (FAM237A) were all reported as agonists of GPR83. However, these results have not yet been reproduced by other laboratories and thus GPR83 is still officially an orphan receptor. The PEN and proCCK56-63 share sequence similarity; however, they are completely different from FAM237A, raising doubts that all of them are ligands of GPR83. To identify its actual ligand(s), in the present study we developed a NanoLuc Binary Technology (NanoBiT)-based ligand-binding assay, fluorescent ligand-based visualization, and a NanoBiT-based β-arrestin recruitment assay for human GPR83. Using these assays, we demonstrated that mature human FAM237A could bind to GPR83 with nanomolar range affinity, which activated this receptor and induced its internalization in transfected human embryonic kidney 293T cells. However, we did not detect any interaction of PEN and proCCK56-63 with GPR83 using these assays. Thus, the results confirmed that FAM237A is an agonist of GPR83, but did not support PEN and proCCK56-63 as ligands of this receptor. Clarification of its actual endogenous agonist will pave the way for further functional studies of this brain-specific receptor. The present study also provided an efficient approach for the preparation of mature FAM237A, which would facilitate further functional studies of this difficult-to-make peptide in the future.

[1]  L. Devi,et al.  GPR83 Engages Endogenous Peptides from Two Distinct Precursors to Elicit Differential Signaling , 2022, Molecular Pharmacology.

[2]  D. Hassabis,et al.  AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models , 2021, Nucleic Acids Res..

[3]  Oriol Vinyals,et al.  Highly accurate protein structure prediction with AlphaFold , 2021, Nature.

[4]  L. Devi,et al.  PEN Receptor GPR83 in Anxiety-Like Behaviors: Differential Regulation in Global vs Amygdalar Knockdown , 2021, bioRxiv.

[5]  W. Kavanaugh,et al.  A Pilot Screen of a Novel Peptide Hormone Library Identified Candidate GPR83 Ligands , 2020, SLAS discovery : advancing life sciences R & D.

[6]  Ming-Hu Han,et al.  The role of the neuropeptide PEN receptor, GPR83, in the reward pathway: Relationship to sex-differences , 2019, Neuropharmacology.

[7]  Zhan-Yun Guo,et al.  Identifying the binding mechanism of LEAP2 to receptor GHSR1a , 2019, The FEBS journal.

[8]  Zhan-Yun Guo,et al.  Development of a novel ligand binding assay for relaxin family peptide receptor 3 and 4 using NanoLuc complementation , 2018, Amino Acids.

[9]  C. Stove,et al.  Molecular dissection of the human A3 adenosine receptor coupling with &bgr;‐arrestin2 , 2018, Biochemical pharmacology.

[10]  Zhan-Yun Guo,et al.  Rapid preparation of bioluminescent tracers for relaxin family peptides using sortase-catalysed ligation , 2017, Amino Acids.

[11]  C. Stove,et al.  Detection and Activity Profiling of Synthetic Cannabinoids and Their Metabolites with a Newly Developed Bioassay. , 2016, Analytical chemistry.

[12]  Zhan-Yun Guo,et al.  Novel Bioluminescent Binding Assays for Ligand–Receptor Interaction Studies of the Fibroblast Growth Factor Family , 2016, PloS one.

[13]  Gunnar Kleinau,et al.  Identification of GPR83 as the receptor for the neuroendocrine peptide PEN , 2016, Science Signaling.

[14]  Zhan-Yun Guo,et al.  Novel bioluminescent binding assays for interaction studies of protein/peptide hormones with their receptors , 2016, Amino Acids.

[15]  Zhan-Yun Guo,et al.  Application of the novel bioluminescent ligand–receptor binding assay to relaxin-RXFP1 system for interaction studies , 2016, Amino Acids.

[16]  Zhan-Yun Guo,et al.  Quick preparation of nanoluciferase-based tracers for novel bioluminescent receptor-binding assays of protein hormones: Using erythropoietin as a model. , 2015, Journal of photochemistry and photobiology. B, Biology.

[17]  Zhan-Yun Guo,et al.  Novel bioluminescent receptor-binding assays for peptide hormones: using ghrelin as a model , 2015, Amino Acids.

[18]  Zhan-Yun Guo,et al.  Nanoluciferase as a novel quantitative protein fusion tag: Application for overexpression and bioluminescent receptor-binding assays of human leukemia inhibitory factor. , 2014, Biochimie.

[19]  Zhan-Yun Guo,et al.  A novel ultrasensitive bioluminescent receptor-binding assay of INSL3 through chemical conjugation with nanoluciferase. , 2013, Biochimie.

[20]  K. Strømgaard,et al.  Recombinant production of peptide C-terminal α-amides using an engineered intein. , 2013, Bioconjugate chemistry.

[21]  S. Woods,et al.  The orphan receptor Gpr83 regulates systemic energy metabolism via ghrelin-dependent and ghrelin-independent mechanisms , 2013, Nature Communications.

[22]  T. Bártfai,et al.  Downregulation of GPR83 in the hypothalamic preoptic area reduces core body temperature and elevates circulating levels of adiponectin. , 2012, Metabolism: clinical and experimental.

[23]  K. Davies,et al.  Gpr83 expression is not required for the maintenance of intestinal immune homeostasis and regulation of T-cell-dependent colitis , 2008, Immunology.

[24]  A. Rudensky,et al.  G Protein-Coupled Receptor 83 Is Dispensable for the Development and Function of Regulatory T Cells , 2007, Molecular and Cellular Biology.

[25]  A. Schnieke,et al.  A method for the amidation of recombinant peptides expressed as intein fusion proteins in Escherichia coli , 2001, Nature Biotechnology.

[26]  L. Fricker,et al.  Distribution of PROSAAS-derived peptides in rat neuroendocrine tissues , 2001, Neuroscience.

[27]  L. Devi,et al.  ProSAAS Processing in Mouse Brain and Pituitary* , 2001, The Journal of Biological Chemistry.

[28]  S. Patterson,et al.  Identification and Characterization of proSAAS, a Granin-Like Neuroendocrine Peptide Precursor that Inhibits Prohormone Processing , 2000, The Journal of Neuroscience.

[29]  Zhan-Yun Guo,et al.  The NanoBiT-Based Homogenous Ligand-Receptor Binding Assay. , 2022, Methods in molecular biology.

[30]  D. Nesheva,et al.  Luciferase Complementation Approaches to Measure GPCR Signaling Kinetics and Bias. , 2021, Methods in molecular biology.

[31]  Jochen,et al.  G Protein-Coupled Receptor 83 Overexpression in Naive CD4 CD25 T Cells Leads to the Induction of Foxp3 Regulatory T Cells In Vivo , 2006 .